IDSA and a coalition of medical professional societies released recommendations for modifying the Centers for Medicare and Medicaid Services sepsis metrics to improve sepsis care and outcomes.
IDSA and a coalition of medical professional societies released recommendations for modifying the Centers for Medicare and Medicaid Services sepsis metrics to improve sepsis care and outcomes.
Wastewater-based surveillance can accurately monitor influenza A and B and RSV at the population level, making it an objective tool to inform public response to common seasonal illnesses, according to research presented at IDWeek 2023.
Two doses of a live-attenuated COVID-19 vaccine candidate produce a broad cellular immune response when administered intranasally, according to research presented at IDWeek 2023.
The Infectious Diseases Society of America is pleased to honor 11 infectious diseases leaders at IDWeek 2023 with Society Awards for their contributions to infectious diseases and public health.
The HIV Medicine Association is pleased to recognize three members during IDWeek 2023 for their contributions to advancing the field of HIV medicine.
The HIV Medicine Association is pleased to announce Allison Agwu, MD, ScM, FAAP, FIDSA, as its new chair. The Association also elected a new vice chair and named five new directors. HIVMA addresses health disparities and inequities in its mission to end the HIV epidemic.
The Infectious Diseases Society of America is pleased to announce Steven K. Schmitt, MD, FIDSA as the Society’s new president beginning Oct. 16.
Personal beliefs and health care system barriers drive antibiotic use without a prescription, according to a new qualitative study.
A newly approved vaccine can substantially reduce the clinical and economic burden of lower respiratory tract disease caused by RSV, according to new findings presented at IDWeek 2023.
IDSA and the HIVMA welcome the U.S. Preventive Services Task Force’s updated statement reaffirming and expanding its Grade A recommendation for pre-exposure prophylaxis for the prevention of HIV among adolescents and adults.
The Senate’s FY 2024 Labor, Health and Human Services and State and Foreign Operations appropriations bills largely flat fund ID programs at FY 2023 levels and provide a few modest increases.
IDSA is disappointed that the House Labor, Health and Human Services Subcommittee did not fund the Bio-Preparedness Workforce Pilot Program in its FY 2024 appropriations bill, missing an opportunity to close the widening ID workforce gap.